Another phenolic acid, bornylcis-4-hydroxycinnamate, was demonstrated to be able to decrease the expression of MMP-2 and MMP-9 by inhibiting FAK/PI3K/Akt/mTOR, MAPK and GRB2 signaling pathways in melanoma cells [163]. This evidence concerns the gene AKT1 and melanoma.